Targeted drug tested for tough cancers with rare genetic flaw
Disease control
Terminated
This study tested whether the drug niraparib could help control advanced solid tumors in patients whose cancer has a specific genetic change called a PALB2 mutation. It involved 22 adults with various cancers (like breast, lung, or pancreatic) that had spread or were locally adva…
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC